Public source
Reviewed 21 Jul 2026
Completeness Strong (64%)
DeepPath LYDIA
DeepPath™DeepPath™–LYDIA is a decision support system for outlining metastases on 20X-40X WSIs of H&E stained lymph node (LN) sections from adult patients with melanoma, breast (female only), colon and lung cancer.
A whole slide image is processed within 2.5 minutes with Sensitivity>99% and a FPR of 9 False Positive segments per LN.
System utilisation accelerates the diagnostic process by up to 5 times per WSI. A much greater efficiency increase is expected because the maximum tumour diameter for all WSIs of a single case is visible at once.
Supported by 1 paper
Key features
Cancer detection in lymph nodes
General Information
Product name
Company
Modality
Main task
Subspeciality
Organ/Specimen source
Not specified
Disease targeted
Specimen type
Not specified
Staining
Stain subtype
Not specified
Regulatory Information
Pathway:
In Vitro Diagnostic Directive (IVDD)
Class:
General IVD Devices
Not verified by Health AI Register
Scanner Brands Certified for Use (CE-IVD)
Not specified
Scanner Models Certified for Use (CE-IVD)
Not specified
Other certifications
Not specified
Technical Specifications
Patient population age
Input
Input format
Output
Not specified
Output format
Not specified
Integration
Deployment
Trigger for analysis
Not specified
Processing time
Population
Viewer systems
Not specified
Market Presence
On market since
AI Platforms
Resellers
Not specified
Countries present
Not specified
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Based on
Source: Public | First published: Jul 30, 2025 | Last updated: Jul 21, 2026